vs
Esperion Therapeutics, Inc.（ESPR）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Esperion Therapeutics, Inc.的1.3倍（$212.2M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 8.6%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
ESPR vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.3倍
$168.4M
营收增速更快
ESPR
高出135.1%
8.6%
两年增速更快
RAMP
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $212.2M |
| 净利润 | — | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | 50.6% | 18.6% |
| 净利率 | — | 18.8% |
| 营收同比 | 143.7% | 8.6% |
| 净利润同比 | — | 255.7% |
| 每股收益（稀释后） | $0.32 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRRAMP
| Q4 25 | $168.4M | $212.2M | ||
| Q3 25 | $87.3M | $199.8M | ||
| Q2 25 | $82.4M | $194.8M | ||
| Q1 25 | $65.0M | $188.7M | ||
| Q4 24 | $69.1M | $195.4M | ||
| Q3 24 | $51.6M | $185.5M | ||
| Q2 24 | $73.8M | $176.0M | ||
| Q1 24 | $137.7M | $171.9M |
净利润ESPRRAMP
| Q4 25 | — | $39.9M | ||
| Q3 25 | $-31.3M | $27.4M | ||
| Q2 25 | $-12.7M | $7.7M | ||
| Q1 25 | $-40.5M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-29.5M | $1.7M | ||
| Q2 24 | $-61.9M | $-7.5M | ||
| Q1 24 | $61.0M | $-5.4M |
毛利率ESPRRAMP
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.1% | ||
| Q1 25 | — | 69.3% | ||
| Q4 24 | — | 71.9% | ||
| Q3 24 | — | 72.4% | ||
| Q2 24 | — | 70.6% | ||
| Q1 24 | — | 72.2% |
营业利润率ESPRRAMP
| Q4 25 | 50.6% | 18.6% | ||
| Q3 25 | -11.4% | 10.7% | ||
| Q2 25 | 8.6% | 3.7% | ||
| Q1 25 | -34.0% | -6.1% | ||
| Q4 24 | -6.4% | 7.5% | ||
| Q3 24 | -31.0% | 4.0% | ||
| Q2 24 | 3.5% | -3.0% | ||
| Q1 24 | 52.5% | -8.3% |
净利率ESPRRAMP
| Q4 25 | — | 18.8% | ||
| Q3 25 | -35.9% | 13.7% | ||
| Q2 25 | -15.4% | 4.0% | ||
| Q1 25 | -62.2% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | -57.2% | 0.9% | ||
| Q2 24 | -83.9% | -4.3% | ||
| Q1 24 | 44.3% | -3.1% |
每股收益（稀释后）ESPRRAMP
| Q4 25 | $0.32 | $0.62 | ||
| Q3 25 | $-0.16 | $0.42 | ||
| Q2 25 | $-0.06 | $0.12 | ||
| Q1 25 | $-0.21 | $-0.10 | ||
| Q4 24 | $-0.14 | $0.17 | ||
| Q3 24 | $-0.15 | $0.03 | ||
| Q2 24 | $-0.33 | $-0.11 | ||
| Q1 24 | $0.34 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $962.3M |
| 总资产 | $465.9M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRRAMP
| Q4 25 | $167.9M | $403.4M | ||
| Q3 25 | $92.4M | $376.9M | ||
| Q2 25 | $86.1M | $371.1M | ||
| Q1 25 | $114.6M | $420.8M | ||
| Q4 24 | $144.8M | $384.3M | ||
| Q3 24 | $144.7M | $348.4M | ||
| Q2 24 | $189.3M | $342.7M | ||
| Q1 24 | $226.6M | $368.9M |
股东权益ESPRRAMP
| Q4 25 | $-302.0M | $962.3M | ||
| Q3 25 | $-451.4M | $943.8M | ||
| Q2 25 | $-433.5M | $947.8M | ||
| Q1 25 | $-426.2M | $948.9M | ||
| Q4 24 | $-388.7M | $957.7M | ||
| Q3 24 | $-370.2M | $932.1M | ||
| Q2 24 | $-344.2M | $951.9M | ||
| Q1 24 | $-294.3M | $949.1M |
总资产ESPRRAMP
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.2B | ||
| Q2 25 | $347.1M | $1.2B | ||
| Q1 25 | $324.0M | $1.3B | ||
| Q4 24 | $343.8M | $1.3B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $1.2B | ||
| Q1 24 | $373.1M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRRAMP
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $57.4M | ||
| Q2 25 | $-31.4M | $-15.8M | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $-35.0M | $45.1M | ||
| Q3 24 | $-35.3M | $55.6M | ||
| Q2 24 | $-7.2M | $-9.3M | ||
| Q1 24 | $53.8M | — |
自由现金流ESPRRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | $56.8M | ||
| Q2 25 | — | $-16.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $44.8M | ||
| Q3 24 | $-35.5M | $55.4M | ||
| Q2 24 | $-7.3M | $-9.6M | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | — | -8.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 22.9% | ||
| Q3 24 | -68.7% | 29.8% | ||
| Q2 24 | -9.9% | -5.4% | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRRAMP
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.3% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 1.0% |
现金转化率ESPRRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RAMP
暂无分部数据
